A human brain proteolytic activity capable of cleaving natural β-amyloid precursor protein is affected by its substrate glycoconjugates

Neuroscience Letters

Volumn 242, Issue 2, 1998, Pages 109-113

  Matsumoto, Akira ^a   Matsumoto, Reiko ^b   Enomoto, Taira ^a   Itoh, Kyoko ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Dept Int Med Osaka Teishin H   (Japan)

Author keywords

amyloid precursor protein; Affinity chromatography; Alzheimer's disease; Protease; Substrate specificity; Sulfated glycoconjugate

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BRAIN PROTEIN; CHONDROITIN ABC LYASE; GLYCOCONJUGATE;

ADULT; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BRAIN; BRAIN CHEMISTRY; CELL FRACTIONATION; CHROMATOGRAPHY, AFFINITY; ENDOPEPTIDASES; FEMALE; GLYCOCONJUGATES; HUMANS; MALE; MIDDLE AGED; SUBSTRATE SPECIFICITY; SULFATES;

EID: 0032512873     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00955-5     Document Type: Article

References (20)

1. Bame K.J., Danda J., Hassall A., Tumova S. Aβ(1-40) prevents heparanase-catalyze degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease. J. Biol. Chem. 272:1997;17005-17011.
2. Caceres J., Brandan E. Interaction between Alzheimer's disease β A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans. J. Cell. Biochem. 65:1997;145-158.
3. Chartier-Harlin M.-C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rosser M., Roques P., Hardy J., Mullan M. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature. 353:1991;844-846.
4. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Kahn K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;593-597.
5. Haass C., Lemere C.A., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L., Selkoe D.J. The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nat. Med. 1:1995;1291-1296.
6. Kjellen L., Lindahl U. Proteoglycans: structures and interactions. Ann. Rev. Biochem. 60:1991;443-475.
7. Koo E.H., Park L., Selkoe D.J. Amyloid β-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc. Natl. Acad. Sci. USA. 90:1993;4748-4752.
8. Levy-Lehad E., Wijsman E.M., Nemens E., Anderson L., Goddard K.A.B., Weber J.L., Bird T.D., Schellenberg G.D. A familial Alzheimer's disease locus on chromosome 1. Science. 269:1995;970-973.
9. Matsumoto A., Fujiwara Y. Aberrant proteolysis of the β-amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cells. Eur. J. Biochem. 217:1993;21-27.
10. 2+-dependent 68-kilodalton protease in familial Alzheimer's disease cells cleaves the N-terminus of β-amyloid. Biochemistry. 33:1994;3941-3948.
11. Matsumoto A., Matsumoto R. Familial Alzheimer's disease cells abnormally accumulate β-amyloid-harbouring peptides preferentially in cytosol but not in extracellular fluid. Eur. J. Biochem. 225:1994;1055-1062.
12. Matsumoto A., Matsumoto R., Baba H., Fujiwara Y. A serin protease in Alzheimer's disease cells cleaves a 16K-peptide with flanking residues upstream to β-amyloid-N-terminus as natural substrate. Neurosci. Lett. 195:1995;171-174.
13. Matsumoto A., Matsumoto R., Enomoto T., Baba H. Human brain β-secretase contains heparan sulfate glycoconjugates. Neurosci. Lett. 211:1996;105-108.
14. Matsumoto A., Enomoto T., Fujiwara Y., Baba H., Matsumoto R. Enhanced aggregation of β-amyloid-containing peptides by extracellular matrix and their degradation by the 68 kDa serine protease prepared from human brain. Neurosci. Lett. 220:1996;159-162.
15. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., Da Silva H.A.R., Haines J.L., Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., St. George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
16. Williamson T.G., Nurcombe V., Beyreuther K., Masters C., Small D.H. Affinity purification of proteoglycans that bind to the amyloid protein precursor of Alzheimer's disease. J. Neurochem. 65:1995;2201-2208.
17. Su J.H., Cummings B.J., Cotman C.W. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience. 51:1992;801-813.
18. Van Broeckhoven C., Hann J., Bakker E., Hardy J.A., Van Hul W., Wehnert A., Vecter-Van der Vis M., Roos R.A.C. Amyloid β protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science. 248:1990;1120-1122.
19. Woods A.G., Cribbs D.H., Whittemore E.R., Cotman C.W. Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate β-amyloid(25-35) induced neurodegeneration in cultured hippocampal neurons. Brain Res. 697:1995;53-62.
20. Yanagisawa K., Odaka A., Suzuki N., Ihara Y. GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1:1995;1062-1066.